Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Early Detection of Cancer | 9 | 2022 | 3070 | 0.910 |
Why?
|
Breast Neoplasms | 10 | 2022 | 20774 | 0.690 |
Why?
|
Tobacco Use Cessation | 2 | 2020 | 95 | 0.690 |
Why?
|
Mammography | 6 | 2021 | 2474 | 0.670 |
Why?
|
Lung Neoplasms | 6 | 2020 | 13019 | 0.560 |
Why?
|
Immunotherapy | 2 | 2017 | 4414 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 1434 | 0.380 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9274 | 0.370 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2016 | 685 | 0.360 |
Why?
|
Tumor Suppressor Proteins | 2 | 2017 | 2842 | 0.340 |
Why?
|
Smoking Cessation | 1 | 2020 | 2068 | 0.310 |
Why?
|
Oxidative Stress | 1 | 2017 | 3081 | 0.280 |
Why?
|
Radiology | 1 | 2020 | 2090 | 0.280 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5724 | 0.240 |
Why?
|
Mass Screening | 5 | 2021 | 5238 | 0.220 |
Why?
|
Maryland | 1 | 2023 | 276 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4554 | 0.210 |
Why?
|
Mental Disorders | 1 | 2022 | 6587 | 0.200 |
Why?
|
Quality of Life | 1 | 2023 | 12730 | 0.200 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5133 | 0.200 |
Why?
|
Internship and Residency | 1 | 2020 | 5774 | 0.180 |
Why?
|
Medically Underserved Area | 1 | 2021 | 253 | 0.170 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 438 | 0.150 |
Why?
|
Accreditation | 1 | 2020 | 449 | 0.150 |
Why?
|
Biopsy, Needle | 1 | 2022 | 1640 | 0.140 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2077 | 0.140 |
Why?
|
Breast | 2 | 2022 | 1958 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2019 | 403 | 0.130 |
Why?
|
Glutathione | 1 | 2017 | 586 | 0.130 |
Why?
|
Iodine | 1 | 2016 | 285 | 0.120 |
Why?
|
Minority Groups | 1 | 2021 | 1215 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13655 | 0.120 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 2 | 2010 | 75 | 0.120 |
Why?
|
Gadolinium DTPA | 1 | 2016 | 836 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 2016 | 665 | 0.110 |
Why?
|
Humans | 20 | 2023 | 742088 | 0.110 |
Why?
|
bcl-2-Associated X Protein | 2 | 2010 | 295 | 0.110 |
Why?
|
Cell Death | 1 | 2017 | 1695 | 0.100 |
Why?
|
Medicare | 2 | 2020 | 6532 | 0.100 |
Why?
|
Apoptosis | 3 | 2017 | 9715 | 0.100 |
Why?
|
Gadolinium | 1 | 2016 | 951 | 0.100 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2010 | 92 | 0.090 |
Why?
|
Low Back Pain | 1 | 2019 | 955 | 0.090 |
Why?
|
United States | 5 | 2020 | 69693 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1440 | 0.090 |
Why?
|
Female | 13 | 2022 | 379592 | 0.090 |
Why?
|
Odds Ratio | 1 | 2022 | 9846 | 0.080 |
Why?
|
Neoplasms | 2 | 2017 | 21596 | 0.080 |
Why?
|
Pandemics | 4 | 2021 | 8328 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3328 | 0.080 |
Why?
|
Glomerular Basement Membrane | 1 | 2008 | 32 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2283 | 0.080 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 883 | 0.080 |
Why?
|
Cathepsins | 1 | 2009 | 239 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20086 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2017 | 5975 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2016 | 5062 | 0.070 |
Why?
|
Cysteine Endopeptidases | 1 | 2009 | 563 | 0.070 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 34 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3151 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 1158 | 0.060 |
Why?
|
Cell Line | 2 | 2017 | 15994 | 0.060 |
Why?
|
Intracellular Space | 1 | 2005 | 212 | 0.060 |
Why?
|
Necrosis | 1 | 2009 | 1643 | 0.060 |
Why?
|
Receptors, Fc | 1 | 2008 | 540 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3915 | 0.060 |
Why?
|
Podocytes | 1 | 2008 | 394 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2019 | 4369 | 0.060 |
Why?
|
Contrast Media | 1 | 2016 | 5295 | 0.060 |
Why?
|
Hospitalization | 1 | 2023 | 10232 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2195 | 0.050 |
Why?
|
Architectural Accessibility | 1 | 2021 | 24 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1366 | 0.050 |
Why?
|
Aged | 5 | 2020 | 162944 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13256 | 0.050 |
Why?
|
Ubiquitin | 1 | 2005 | 849 | 0.050 |
Why?
|
Risk Assessment | 1 | 2021 | 23320 | 0.050 |
Why?
|
Time | 1 | 2021 | 530 | 0.040 |
Why?
|
DNA Damage | 1 | 2009 | 2423 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 2948 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4553 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2021 | 77098 | 0.040 |
Why?
|
Adult | 3 | 2023 | 213712 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7645 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3770 | 0.040 |
Why?
|
Social Stigma | 1 | 2022 | 698 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4554 | 0.030 |
Why?
|
Mice | 4 | 2017 | 81045 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57683 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2019 | 780 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40054 | 0.030 |
Why?
|
Middle Aged | 5 | 2021 | 213127 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7873 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 72145 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35342 | 0.030 |
Why?
|
Outpatients | 1 | 2019 | 1483 | 0.020 |
Why?
|
Health Services Research | 1 | 2019 | 1834 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9325 | 0.020 |
Why?
|
Protein Transport | 2 | 2008 | 1988 | 0.020 |
Why?
|
Animals | 4 | 2017 | 168561 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 56350 | 0.020 |
Why?
|
Cytochromes c | 1 | 2010 | 180 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2680 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2010 | 390 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4030 | 0.020 |
Why?
|
Permeability | 1 | 2010 | 738 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 85649 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2019 | 2706 | 0.020 |
Why?
|
Caspases | 1 | 2010 | 928 | 0.020 |
Why?
|
Nephritis | 1 | 2008 | 158 | 0.020 |
Why?
|
Serum | 1 | 2008 | 212 | 0.020 |
Why?
|
Male | 3 | 2020 | 349538 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2010 | 971 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2005 | 166 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2085 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2005 | 215 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2010 | 14554 | 0.010 |
Why?
|
Mutant Proteins | 1 | 2005 | 500 | 0.010 |
Why?
|
Cerebellum | 1 | 2010 | 1490 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2010 | 1402 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13921 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1782 | 0.010 |
Why?
|
Cytosol | 1 | 2005 | 901 | 0.010 |
Why?
|
Ubiquitination | 1 | 2005 | 1011 | 0.010 |
Why?
|
Lysine | 1 | 2005 | 1008 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2009 | 4771 | 0.010 |
Why?
|
HeLa Cells | 1 | 2005 | 3127 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3847 | 0.010 |
Why?
|
Fibroblasts | 1 | 2009 | 4143 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 24913 | 0.010 |
Why?
|
Mitochondria | 1 | 2010 | 3520 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40450 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19223 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9581 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10163 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14720 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 16665 | 0.010 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_